Inotrem
PrivateLast Round
Grant
Nov 6, 2023
Total Funding Raised
$142.25M
Momentum Score
50 /100
Company Overview
Inotrem is a biotechnology company that develops innovative therapeutics aimed at treating inflammatory diseases through targeted immunotherapy for acute inflammatory syndromes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inotrem Comps
Public and private peers based on sector, stage, and business model.
Inotrem Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 6, 2023 | ||||
| Grant | Dec 1, 2022 | ||||
| Grant | Jul 12, 2021 | ||||
| Series B Extension | Feb 11, 2020 | ||||
| Debt | Feb 11, 2020 | ||||
Series B | Sep 12, 2019 |
Key People
Founding team and executive leadership
Inotrem Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kreos Capital | Debt |
| BioMedPartners | Series A, Series B |
| Andera Partners | Series B |
| Inserm Transfert | Series A |
| Bpifrance | Grant, Debt |
| Edmond de Rothschild | Series A |
| Fountain Healthcare Partners | Series B Extension |
Inotrem Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Inotrem's valuation, stock price, and market status.
